Scope 46 - News under the microscope
25 October 2011, Supporting the Malaghan Institute
Malaghan Institute in the Media Spotlight
In early September, the Malaghan Institutes Immunoglycomics Group Leader, Dr Bridget Stocker, was interviewed on the Radio New Zealand Nine to Noon programme. Dr Stocker was recently recognised in a special edition of the European Journal of Organic Chemistry, dedicated to women in chemistry who have made a significant contribution to their field and spoke about some of her research in her interview with Kathryn Ryan.
Also in September, a TVNZ crew visited the Institute to film a story about our Allergy research. This research has just been granted HRC funding and is making exciting inroads into better understanding the allergic response and childhood food allergies. Reporter Rebecca Edwards interviewed Prof Graham Le Gros about the research and the progress being made.
Rotary Club of Port Nicholson donates $20,000
The Rotary Club of Port Nicholson held their annual Charity dinner and Auction in May with the proceeds to be split between three worthy charities. The Malaghan Institute was the main recipient and recently was presented with a very generous cheque for $20,000. This will be used to fund the purchase of our new Immuno-Histo-Chemistry Station, a new cutting-edge technology that will be of importance to our future research work.
Malaghan PhD student finalist in Prime Ministers Prize
Top achieving Malaghan PhD student, Emma Dangerfield, has progressed to the final round of the Prime Ministers Prize. Emma is nominated in the Prime Ministers MacDiarmid Emerging Scientist category and gave her address to the panel in late August. The winners will not be announced until early 2012, but we wish Emma all the best!
New Senior Research Fellow welcomed
The Institute welcomes new Senior Research Fellow, Dr Olivier Gasser, who comes to us all the way from Germany. Dr Gasser is here to work on the new Melanoma Clinical Trial which has begun its preparatory work. He will be working closely with Dr Ian Hermans with hopes that the trial itself will be ready to start in late 2012. Welcome Dr Gasser!